Commentary: Surgical aortic valve replacement after transcatheter aortic valve replacement: Is it time to reconsider the lifelong management?
作者信息
Bando Ko, Ogawa Takayuki
机构信息
Department of Cardiac Surgery, The Jikei University School of Medicine, Tokyo, Japan.
Division of Cardiology, Department of Medicine, The Jikei University School of Medicine, Tokyo, Japan.
出版信息
J Thorac Cardiovasc Surg. 2023 Jun;165(6):2024-2025. doi: 10.1016/j.jtcvs.2021.10.035. Epub 2021 Oct 29.
PMID:34799092
Abstract
摘要
相似文献
1
Commentary: Surgical aortic valve replacement after transcatheter aortic valve replacement: Is it time to reconsider the lifelong management?评论：经导管主动脉瓣置换术后的外科主动脉瓣置换术：是时候重新考虑终身管理了吗？
J Thorac Cardiovasc Surg. 2023 Jun;165(6):2024-2025. doi: 10.1016/j.jtcvs.2021.10.035. Epub 2021 Oct 29.
2
Editorial commentary: Selection of transcatheter heart valves: The plethora of device-specific, anatomic-specific and patient-specific aspects for optimal results in transcatheter aortic valve replacement.编辑评论：经导管心脏瓣膜的选择：在经导管主动脉瓣置换术中实现最佳效果所需考虑的大量特定器械、特定解剖结构和特定患者因素。
Trends Cardiovasc Med. 2022 Nov;32(8):523-524. doi: 10.1016/j.tcm.2021.10.003. Epub 2021 Oct 19.
3
Incorporating Redo-TAVR Feasibility Into Lifelong Aortic Valve Management.将再次经导管主动脉瓣置换术的可行性纳入终身主动脉瓣管理中。
Circ Cardiovasc Interv. 2023 Nov;16(11):e013571. doi: 10.1161/CIRCINTERVENTIONS.123.013571. Epub 2023 Nov 21.
4
Surgical Replacement After Transcatheter Aortic Valve Replacement Due to Device Distortion.经导管主动脉瓣置换术后因装置扭曲而行外科置换术
Semin Thorac Cardiovasc Surg. 2020;32(4):857-859. doi: 10.1053/j.semtcvs.2019.06.012. Epub 2019 Jul 10.
5
Valve-in-Valve Transcatheter Aortic Valve Replacement Following 2 Surgical Aortic Valve Replacements.在两次外科主动脉瓣置换术后进行经导管主动脉瓣置入术（瓣中瓣技术）
Circ Cardiovasc Interv. 2023 Nov;16(11):e013305. doi: 10.1161/CIRCINTERVENTIONS.123.013305. Epub 2023 Nov 21.
6
Advancing Transcatheter Aortic Valve Replacement to the Frontiers of Lifetime Valve Management: Deliberations From the OBSERVANT II Trial.将经导管主动脉瓣置换术推进到终身瓣膜管理的前沿：来自OBSERVANT II试验的研讨
Circ Cardiovasc Interv. 2022 Dec;15(12):e012607. doi: 10.1161/CIRCINTERVENTIONS.122.012607. Epub 2022 Dec 9.
7
Commentary: Should valve-in-valve transcatheter aortic valve replacement be first-line treatment for failed aortic bioprostheses?评论：对于失败的主动脉生物瓣膜，经导管主动脉瓣置换术（瓣中瓣技术）应作为一线治疗方法吗？
J Thorac Cardiovasc Surg. 2022 May;163(5):1800-1802. doi: 10.1016/j.jtcvs.2021.01.061. Epub 2021 Jan 28.
8
Technical Considerations for Transcatheter Aortic Valve Replacement With the Navitor Transcatheter Heart Valve.使用Navitor经导管心脏瓣膜进行经导管主动脉瓣置换术的技术考量
JACC Cardiovasc Interv. 2021 Oct 11;14(19):e259-e261. doi: 10.1016/j.jcin.2021.06.034. Epub 2021 Sep 15.
9
Transcatheter Versus Surgical Aortic Valve Replacement in Cardiac Amyloidosis.心脏淀粉样变性中经导管与外科主动脉瓣置换术的比较
Cardiovasc Revasc Med. 2022 Oct;43:150. doi: 10.1016/j.carrev.2022.05.036. Epub 2022 May 31.
10
Commentary: When less is not more-volume-outcome relationships in aortic valve replacement.评论：主动脉瓣置换术中并非量少就好——容量与结局的关系
J Thorac Cardiovasc Surg. 2022 Jun;163(6):2053-2055. doi: 10.1016/j.jtcvs.2020.07.068. Epub 2020 Jul 25.
Zotero 插件